Reproductive Health

The authors note that this finding may have promise for use in assessing mental health conditions and improving patient outcomes.

The study’s co-primary endpoint of overall survival was not formally tested due to DFS not being reached.

A new treatment for postpartum depression has been developed with rapid onset, cutting down the time it has taken previous treatments to take effect by weeks or months.

Pharmacists play a multifaceted role beyond dispensing medications, serving as educators, counselors, advocates, and pillars of emotional support for individuals and couples confronting infertility.

The approval is based on data from Study 5310, evaluating the pharmacokinetics, safety, and efficacy of Biktarvy (Gilead Sciences Inc) in pregnant individuals.

Dostarlimab plus chemotherapy is the only immuno-oncology-based therapy that showed statistically significant and clinically meaningful survival benefit in the overall patient population.

With the first FDA-approved option hitting shelves soon, pharmacists can advise patients on the best methods to prevent pregnancy

Access to birth control is a crucial part of preventive health care, but financial barriers persist

Opill is a nonprescription, progestin-only contraceptive pill, with nearly 50 years of use and data supporting the safety and effectiveness of progestin-only pills.

Although there are medical considerations for patients with psychiatric conditions, prescribers must consider patient preference to increase adherence and effectiveness of contraception.

The authors note that these findings provide opportunities for health care professionals to utilize social media to reach patients and share accurate information.

In December 2023, nipocalimab (Johnson & Johnson) was granted orphan drug designation for fetal neonatal alloimmune thrombocytopenia.

The state order was signed on Tuesday and is just a part of an overall mission to strengthen and protect reproductive rights within New York for citizens and those out of state.

Fortification with folic acid may be especially beneficial in countries that do not have mandated folic acid fortification regulations.

Oteseconazole (Vivjoa; Mycovia Pharmaceutical Inc) is the first and only medication for this indication in postmenopausal women and those who do not have reproductive potential.

Tacrolimus is a selective calcineurin inhibitor that exerts inhibitory effects on T-cell proliferation.

The early phase clinical trial, which ended prematurely in 2013 due to funding challenges, further illustrates disparities in health equity in clinical research.

There have been ongoing concerns about the long-term effects of prenatal exposure on neurodevelopment.

The CBT-based intervention, compared with routine pregnancy care, demonstrated reductions of 81% and 74% for depression and anxiety, respectively.

Walgreens will start dispensing the abortion pill as soon as a week.

In a study, nipocalimab helped more than 50% of patients with high-risk of hemolytic disease of the fetus and newborn achieve a safe live birth.

Providing continuity of care with the involvement of midwives also appeared to reduce inequities in care for multi-ethnic patients.

However, different recommendations may actually be valuable, as different countries have different population-based needs.

Supplementation during pregnancy also reduced communication warning behaviors in children who developed autism compared to the children of women who did not take supplements.